Literature DB >> 27271769

Epinephrine auto-injector needle length: what is the ideal length?

T Ted Song1, Phil Lieberman.   

Abstract

PURPOSE OF REVIEW: The purpose of this manuscript is to review the literature on the clinical effects of the needle length of epinephrine (adrenaline) auto-injectors. RECENT
FINDINGS: Epinephrine has maximal pharmacodynamic effect within 10 min of intramuscular administration into the thigh. Prefilled epinephrine auto-injectors are designed for simplicity of use and safety. Auto-injectors are primarily used by patients in an unsupervised setting in cases of anaphylaxis. There are weight-appropriate doses of epinephrine available with auto-injectors that are prefilled, to prevent dosing errors, with 0.15, 0.30, and 0.50 mg amounts. In addition, needle lengths vary from 1.17 to 2.50 cm. The recommended needle lengths differ between adults and pediatric patients. In addition, the needle lengths differ between devices as well. There are concerns that the needle length may be too short in select obese patients. Yet, there are also concerns that the needle length may be too long in some patients. Factors that affect the depth of the injection, and therefore the pharmacokinetics of the drug, include not only the needle length but also the BMI, obesity, compression of soft tissue, and propulsion.
SUMMARY: Epinephrine auto-injectors have different needle lengths. Using the right device with appropriate needle length based on BMI, obesity, and employing the proper technique can improve the outcome in an anaphylactic event.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27271769     DOI: 10.1097/ACI.0000000000000283

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  4 in total

1.  Ideal body position for epinephrine autoinjector administration.

Authors:  Qing Wang; Luke Pittman; Andrew Healey; James Chang; T Ted Song
Journal:  Allergy Asthma Proc       Date:  2021-03-21       Impact factor: 2.587

2.  Efficacy of a Novel Prefilled, Single-Use, Needle-Free Device (Zeneo®) in Achieving Intramuscular Agent Delivery: An Observational Study.

Authors:  Marc Bardou; Maxime Luu; Paul Walker; Christophe Auriel; Xavière Castano
Journal:  Adv Ther       Date:  2016-12-07       Impact factor: 3.845

3.  Unintentional injection to the bone with a pediatric epinephrine auto-injector.

Authors:  Mariam Ibrahim; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2018-08-20       Impact factor: 3.406

4.  Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances.

Authors:  Margitta Worm; DucTung Nguyen; Russ Rackley; Antonella Muraro; George Du Toit; Tracey Lawrence; Hong Li; Kurt Brumbaugh; Magnus Wickman
Journal:  Clin Transl Allergy       Date:  2020-06-10       Impact factor: 5.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.